Published in Clin Endocrinol (Oxf) on May 26, 2009
Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne) (2011) 1.00
Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience. Front Endocrinol (Lausanne) (2011) 0.98
Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy. Int J Pediatr Endocrinol (2011) 0.96
Obesity and craniopharyngioma. Ital J Pediatr (2011) 0.81
Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention. J Clin Med (2015) 0.78
Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. Eur J Pediatr (2010) 0.77
Giant craniopharyngiomas in children: short- and long-term implications. Childs Nerv Syst (2015) 0.77
Activation of nuclear factor kappa B pathway and reduction of hypothalamic oxytocin following hypothalamic lesions. J Syst Integr Neurosci (2016) 0.75
Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. Ann Pediatr Endocrinol Metab (2017) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev (2002) 4.41
Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem (2013) 3.58
Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) (2005) 3.23
Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr (2005) 3.08
Type 1 diabetes and autism: is there a link? Diabetes Care (2005) 2.24
Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes (2009) 2.14
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem (2009) 2.00
Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab (2010) 1.97
Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem (2012) 1.90
Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am J Physiol Endocrinol Metab (2009) 1.88
Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency. J Clin Endocrinol Metab (2012) 1.85
Diabetic ketoacidosis. Pediatr Diabetes (2007) 1.83
A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype. Exp Neurol (2007) 1.82
Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev (2007) 1.79
Routine psychological screening in youth with type 1 diabetes and their parents: a notion whose time has come? Diabetes Care (2007) 1.77
Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta (2006) 1.73
European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics (2004) 1.71
Analytical evaluation of the VITROS 5600 Integrated System in a pediatric setting and determination of pediatric reference intervals. Clin Biochem (2010) 1.61
Malnourishment in a population of young children with severe early childhood caries. Pediatr Dent (2006) 1.56
CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem (2013) 1.52
Transition to adult care for youths with diabetes mellitus: findings from a Universal Health Care System. Pediatrics (2009) 1.51
Glucose intolerance in children with cystic fibrosis. J Pediatr (2003) 1.51
Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala. Pediatr Blood Cancer (2012) 1.51
Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy. J Pediatr (2012) 1.48
Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol (2008) 1.47
Quality of life and anxiety in adolescents with differentiated thyroid cancer. J Clin Endocrinol Metab (2012) 1.44
Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty. Arch Dis Child (2013) 1.42
Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone. Horm Res (2007) 1.41
Early onset of severe diabetes mellitus-related microvascular complications. J Pediatr (2004) 1.41
Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr (2002) 1.40
A patient with a leg rash, pedal edema, renal failure, and thrombocytopenia. Clin Chem (2009) 1.39
Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children. Pediatr Diabetes (2009) 1.37
Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr (2008) 1.36
Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. J Lipid Res (2010) 1.36
Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol (2004) 1.33
Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study. Diabetes Care (2004) 1.33
Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr (2007) 1.33
Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr (2006) 1.32
Prolactin levels during long-term risperidone treatment in children and adolescents. J Clin Psychiatry (2003) 1.32
Is diabetic ketoacidosis at disease onset a result of missed diagnosis? J Pediatr (2009) 1.29
Prediction of the onset of disturbed eating behavior in adolescent girls with type 1 diabetes. Diabetes Care (2008) 1.28
The link between social inequality and child health outcomes. Healthc Q (2010) 1.27
Predictors of glucose control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes (2005) 1.26
Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med (2011) 1.25
Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance. Hepatology (2009) 1.24
Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin Biochem (2012) 1.23
Gut-liver interaction in triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab (2011) 1.22
Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol (2012) 1.21
MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly. Arterioscler Thromb Vasc Biol (2006) 1.20
Deteriorating diabetes control during adolescence: physiological or psychosocial? J Pediatr Endocrinol Metab (2002) 1.19
Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome. Clin Biochem (2006) 1.18
Five-year prevalence and persistence of disturbed eating behavior and eating disorders in girls with type 1 diabetes. Diabetes Care (2007) 1.17
MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol (2012) 1.17
Children, cancer, and nutrition--A dynamic triangle in review. Cancer (2004) 1.16
Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res (2002) 1.16
Clinical laboratory reference intervals in pediatrics: the CALIPER initiative. Clin Biochem (2009) 1.15
Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology (2009) 1.15
Quality of life of African American cancer survivors. A review of the literature. Cancer (2007) 1.13
A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem (2005) 1.12
Motivational interviewing to enhance self-efficacy and promote weight loss in overweight and obese adolescents: a randomized controlled trial. J Pediatr Psychol (2013) 1.12
Recent trends in hospitalization for diabetic ketoacidosis in ontario children. Diabetes Care (2002) 1.11
Association of anthropometric indices with cardiovascular disease risk factors among children and adolescents: CASPIAN Study. Int J Cardiol (2006) 1.11
Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr (2005) 1.11
Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin Biochem (2010) 1.10
Motivational interviewing as an intervention to increase adolescent self-efficacy and promote weight loss: methodology and design. BMC Public Health (2011) 1.10
The global burden of youth diabetes: perspectives and potential. Pediatr Diabetes (2007) 1.08
Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care (2003) 1.07
Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation. Arterioscler Thromb Vasc Biol (2002) 1.07
Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation. Arterioscler Thromb Vasc Biol (2004) 1.07
Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly. Biochem Cell Biol (2010) 1.07
Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem (2003) 1.05
Canadian Laboratory Initiative on Pediatric Reference Interval Database (CALIPER): pediatric reference intervals for an integrated clinical chemistry and immunoassay analyzer, Abbott ARCHITECT ci8200. Clin Biochem (2009) 1.04
Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas. Int J Pediatr Endocrinol (2010) 1.04
Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization. Atherosclerosis (2008) 1.04
Translating transition: a critical review of the diabetes literature. J Pediatr Endocrinol Metab (2008) 1.04
GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes (2012) 1.03
Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Am J Physiol Gastrointest Liver Physiol (2009) 1.03
Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer (2011) 1.03
Factors associated with the metabolic syndrome in a national sample of youths: CASPIAN Study. Nutr Metab Cardiovasc Dis (2007) 1.03
Closing the gaps in paediatric reference intervals: the CALIPER initiative. Clin Biochem Rev (2008) 1.02
C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology (2010) 1.02
Incidental thyroid abnormalities identified on neck US for non-thyroid disorders. Pediatr Radiol (2010) 1.01
Relationship between C-reactive protein and atherosclerotic risk factors and oxidative stress markers among young persons 10-18 years old. Clin Chem (2007) 1.00
Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord (2010) 1.00
Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. Br J Nutr (2008) 1.00
The effects of psychoeducation on disturbed eating attitudes and behavior in young women with type 1 diabetes mellitus. Int J Eat Disord (2002) 1.00
Hepatic autophagy mediates endoplasmic reticulum stress-induced degradation of misfolded apolipoprotein B. Hepatology (2011) 0.99
Cord blood lipid profile and associated factors: baseline data of a birth cohort study. Paediatr Perinat Epidemiol (2007) 0.99
Congenital hypothyroidism: a review of current diagnostic and treatment practices in relation to neuropsychologic outcome. Paediatr Drugs (2003) 0.99
Long-term stability of biochemical markers in pediatric serum specimens stored at -80 °C: a CALIPER Substudy. Clin Biochem (2012) 0.98
Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion. Front Biosci (2003) 0.98
Perceptions of cancer fatalism and cancer knowledge: a comparison of older and younger African American women. J Psychosoc Oncol (2006) 0.98
Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience. Front Endocrinol (Lausanne) (2011) 0.98
Autophagy: Emerging roles in lipid homeostasis and metabolic control. Biochim Biophys Acta (2012) 0.98
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Am J Respir Crit Care Med (2011) 0.98